Physician profile
Lorra Marie Sharp
NPI 1689689176
$1,872.57
in general payments reported to CMS, 2019-2025
8 companies · $36.38 in 2025
The $36.38 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $206 · 2021: $147 · 2022: $177 · 2023: $498 · 2024: $331 · 2025: $36.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $530 · Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $530.42 |
| Food and Beverage | $334.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $763.26 | 2019-2024 | Na, Motoband |
| Integra Lifesciences Corporation | $613.40 | 2022-2025 | Acell, Integra, Primatrix |
| Stryker Corporation | $267.11 | 2019-2020 | |
| Bioventus LLC | $126.40 | 2019-2022 | |
| Si-Bone, INC. | $41.49 | 2021-2022 | |
| Kerecis Limited | $32.49 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Elevate Surgical Co | $14.86 | 2023 | |
| Sanofi-Aventis U.S. LLC | $13.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorra Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.